Subscribe to RSS
DOI: 10.1055/a-2552-8692
The Trigeminal Nerve in Diabetes Mellitus: A Brief Narrative Review

Abstract
This brief narrative review discusses the clinical manifestations, diagnosis, and management of trigeminal nerve-related conditions, such as neuropathy and neuralgia, in patients with diabetes mellitus. Although these conditions are not very common, there is a solid connection between them in diabetes patients. Symptoms typically include facial pain, sensory disturbances, and muscle weakness for neuropathy and severe, stabbing pain for neuralgia. Diagnosis is based on characteristic clinical manifestations, along with laboratory investigation and magnetic resonance imaging to exclude other potential causes, such as tumours, multiple sclerosis, or vascular compression. Treatment focuses on strict glycaemic control, modification of vascular risk factors, pharmacological agents (carbamazepine and oxcarbazepine), and neurostimulation to improve symptoms and quality of life.
Keywords
cranial nerves - diabetes mellitus - diabetic neuropathy - trigeminal nerve - trigeminal neuralgia - mononeuropathyPublication History
Received: 07 January 2025
Accepted after revision: 06 March 2025
Accepted Manuscript online:
06 March 2025
Article published online:
24 April 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Feldman EL, Callaghan BC, Pop-Busui R. et al. Diabetic neuropathy. Nat Rev Dis Primers 2019; 5: 41
- 2 Stamatiou I, Papachristou S, Papanas N. Diabetes mellitus and Bell's palsy. Curr Diabetes Rev 2023; 19: e080322201913
- 3 Pantazopoulos D, Gouveri E, Papazoglou D. et al Ocular motor mononeuropathies in diabetes mellitus: A brief review. Exp Clin Endocrinol Diabetes 2024; Nov 7. Online ahead of print
- 4 Samakidou G, Eleftheriadou I, Tentolouris A. et al. Rare diabetic neuropathies: It is not only distal symmetrical polyneuropathy. Diabetes Res Clin Pract 2021; 177: 108932
- 5 Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol 2014; 126: 63-79
- 6 Vinik AI, Maser RE, Mitchell BD. et al. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579
- 7 Carter E, Yilmaz Z, Devine M. et al. An update on the causes, assessment and management of third division sensory trigeminal neuropathies. Br Dent J 2016; 220: 627-635
- 8 Bathla G, Hegde AN. The trigeminal nerve: An illustrated review of its imaging anatomy and pathology. Clin Radiol 2013; 68: 203-213
- 9 Veerapaneni KD, Kapoor N, Veerapaneni P. et al. Trigeminal neuropathy. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024. Updated March 1, 2024. Accessed December 19, 2024
- 10 Hanewinckel R, Ikram MA, Van Doorn PA. Peripheral neuropathies. Handb Clin Neurol 2016; 138: 263-282
- 11 Wong AD, Best JA, Shapiro RD. Diabetic polyneuropathy involving the maxillofacial region: A case report. J Oral Maxillofac Surg 2002; 60: 935-938
- 12 Casamassimo PS, Tucker-Lammertse JE. Diabetic polyradiculopathy with trigeminal nerve involvement. A case report. Oral Surg Oral Med Oral Pathol 1988; 66: 315-317
- 13 Xu Z, Zhang P, Long L. et al. Diabetes mellitus in classical trigeminal neuralgia: A predisposing factor for its development. Clin Neurol Neurosurg 2016; 151: 70-72
- 14 AlZailaie AK, Aseeri AM, Algahtany AM. et al. Prevalence of and risk factors for cranial neuropathy in diabetic and non-diabetic patients. Eur Rev Med Pharmacol Sci 2023; 27: 4990-4997
- 15 Finestone AJ, Choudhry M, Shenkin HA. Trigeminal neuralgia and diabetes mellitus. J Med Soc N J 1970; 67: 269-270
- 16 Collis JS, Wallace TW. Tic douloureux and diabetes mellitus. Cleve Clin Q 1968; 35: 155-157
- 17 Arap A, Siqueira SR, Silva CB. et al. Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch Oral Biol 2010; 55: 486-493
- 18 Urban PP, Forst T, Lenfers M. et al. Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitus. Electromyogr Clin Neurophysiol 1999; 39: 267-272
- 19 Kazem SS, Behzad D. Role of blink reflex in diagnosis of subclinical cranial neuropathy in diabetic mellitus type II. Electromyogr Clin Neurophysiol 2005; 45: 299-303
- 20 Birlea M, Nagel MA, Khmeleva N. et al. Varicella-zoster virus trigeminal ganglioneuritis without rash. Neurology 2014; 82: 90-92
- 21 Tidwell E, Hutson B, Burkhart N. et al. Herpes zoster of the trigeminal nerve third branch: A case report and review of the literature. Int Endod J 1999; 32: 61-66
- 22 Keskinruzgar A, Demirkol M, Ege B. et al. Rare involvement of herpes zoster in the mandibular branch of the trigeminal nerve: A case report and review of the literature. Quintessence Int 2015; 46: 163-170
- 23 Weitzman D, Shavit O, Stein M. et al. A population based study of the epidemiology of Herpes Zoster and its complications. J Infect 2013; 67: 463-469
- 24 Suaya JA, Chen SY, Li Q. et al. Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States. Open Forum Infect Dis 2014; 1: ofu049
- 25 Papagianni M, Metallidis S, Tziomalos K. Herpes zoster and diabetes mellitus: A review. Diabetes Ther 2018; 9: 545-550
- 26 Torcel-Pagnon L, Bricout H, Bertrand I. et al. Impact of underlying conditions on zoster-related pain and on quality of life following zoster. J Gerontol A Biol Sci Med Sci 2017; 72: 1091-1097
- 27 Chen HH, Lin IC, Chen HJ. et al. Association of herpes zoster and type 1 diabetes mellitus. PLoS ONE 2016; 11: e0155175
- 28 Bosco D, Plastino M, De Bartolo M. et al. Role of impaired glucose metabolism in the postherpetic neuralgia. Clin J Pain 2013; 29: 733-736
- 29 Agbaje JO, Van de Casteele E, Hiel M. et al. Neuropathy of trigeminal nerve branches after oral and maxillofacial treatment. J Maxillofac Oral Surg 2016; 15: 321-327
- 30 Yao AL, Barad M. Diagnosis and management of chronic facial pain. BJA Educ 2020; 20: 120-125
- 31 Di Stefano G, Maarbjerg S, Nurmikko T. et al. Triggering trigeminal neuralgia. Cephalalgia 2018; 38: 1049-1056
- 32 Takayama S, Osawa M, Takahashi Y. et al. Painful neuropathy with trigeminal nerve involvement in type 2 diabetes. J Int Med Res 2006; 34: 115-118
- 33 Kochar DK, Agarwal N, Thanvi I. et al. Isolated bilateral fifth cranial nerve paralysis with autonomic neuropathy in a case of insulin dependent diabetes mellitus. J Assoc Physicians India 1998; 46: 975-976
- 34 Dumas M, Pérusse R. Trigeminal sensory neuropathy: A study of 35 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 577-582
- 35 Gladstone JP. An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa-Hunt syndrome. Curr Pain Headache Rep 2007; 11: 317-325
- 36 Lasam G, Kapur S. A rare case of Tolosa-Hunt-like syndrome in a poorly controlled diabetes mellitus. Case Rep Med 2016; 2016: 9763621
- 37 Zou X, Lu L, Xu Y. et al. Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: The Beixinjing eye study. BMC Ophthalmol 2018; 18: 117
- 38 Fang W, Lin ZX, Yang HQ. et al. Changes in corneal nerve morphology and function in patients with dry eyes having type 2 diabetes. World J Clin Cases 2022; 10: 3014-3026
- 39 Tavakoli M, Kallinikos PA, Efron N. et al. Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diabetes Care 2007; 30: 1895-1897
- 40 Moore PA, Guggenheimer J, Orchard T. Burning mouth syndrome and peripheral neuropathy in patients with type 1 diabetes mellitus. J Diabetes Complications 2007; 21: 397-402
- 41 Scala A, Checchi L, Montevecchi M. et al. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275-291
- 42 Lauria G, Majorana A, Borgna M. et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 332-337
- 43 Miller JP, Acar F, Burchiel KJ. Classification of trigeminal neuralgia: Clinical, therapeutic, and prognostic implications in a series of 144 patients undergoing microvascular decompression. J Neurosurg 2009; 111: 1231-1234
- 44 Galán Gil S, Peñarrocha Diago M, Peñarrocha Diago M. Malignant mental nerve neuropathy: A systematic review. Med Oral Patol Oral Cir Bucal 2008; 13: E616-E621
- 45 Sabalys G, Juodzbalys G, Wang HL. Aetiology and pathogenesis of trigeminal neuralgia: A comprehensive review. J Oral Maxillofac Res 2013; 3: e2
- 46 Stino AM, Rumora AE, Kim B. et al. Evolving concepts on the role of dyslipidemia, bioenergetics, and inflammation in the pathogenesis and treatment of diabetic peripheral neuropathy. J Peripher Nerv Syst 2020; 25: 76-84
- 47 Cernea S, Raz I. Management of diabetic neuropathy. Metabolism 2021; 123: 154867
- 48 Saadatian-Elahi M, Bauduceau B, Del-Signore C. et al. Diabetes as a risk factor for herpes zoster in adults: A synthetic literature review. Diabetes Res Clin Pract 2020; 159: 107983
- 49 Kornelius E, Lo SC, Huang CN. et al. Assessing herpes zoster vaccine efficacy in patients with diabetes: A community-based cohort study. J Med Virol 2024; 96: e29667
- 50 Du Z, Zhang J, Han X. et al. Potential novel therapeutic strategies for neuropathic pain. Front Mol Neurosci 2023; 16: 1138798
- 51 Cruccu G, Gronseth G, Alksne J. et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013-1028
- 52 Zheng Y, Liu CW, Hui Chan DX. et al. Neurostimulation for chronic pain: A systematic review of high-quality randomized controlled trials with long-term follow-up. Neuromodulation 2023; 26: 1276-1294
- 53 Bisla S, Gupta A, Agarwal S. et al. Evaluation of transcutaneous electrical nerve stimulation as an adjunct therapy in trigeminal neuralgia – a randomized double-blind placebo-controlled clinical study. J Dent Anesth Pain Med 2021; 21: 565-574
- 54 Lefaucheur JP, Drouot X, Cunin P. et al. Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain. Brain 2009; 132: 1463-1471
- 55 Wu CJ, Lian YJ, Zheng YK. et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo-controlled trial. Cephalalgia 2012; 32: 443-450
- 56 Apalla Z, Sotiriou E, Lallas A. et al. Botulinum toxin A in postherpetic neuralgia: A parallel, randomized, double-blind, single-dose, placebo-controlled trial. Clin J Pain 2013; 29: 857-864
- 57 Xiao L, Mackey S, Hui H. et al. Subcutaneous injection of botulinum toxin A is beneficial in postherpetic neuralgia. Pain Med 2010; 11: 1827-1833